EUVIMEDEUVIMED entdecken
Crossref

Differential modulation of Bruton's tyrosine kinase inhibitor selectivity on platelet GPVI and integrin αIIbβ3 bidirectional signalling via BTK / PLCγ2 / PKCθ affects haemostasis and thrombosis

Teng Zhang, Shan Du, Gongwei Han, Hanbing Shi, Ziwei Cheng, Shuhui Wang, Yuxuan Guan, Zhangbiao Long, Quan Xia iD

British Journal of Haematology · 2025

DOI: 10.1111/bjh.70029 ↗

Kurz gefasst

Fachartikel in der Zeitschrift British Journal of Haematology, 2025. Verfasst von Teng Zhang und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, First Affiliated Hospital of Anhui Medical University, Hefei, China. Hauptthemen laut MEDLINE: Agammaglobulinaemia Tyrosine Kinase, Thrombosis, Platelet Membrane Glycoproteins, Signal Transduction. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 40 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Traditional Chinese Medicine Inheritance and Innovation Research Project of Anhui Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The selectivity of Bruton's tyrosine kinase inhibitors (BTKi) affects the activation of platelet integrin αIIbβ3 differently, and this is related to the glycoprotein VI (GPVI) pathway. However, the distinct regulatory mechanisms remain to be further unravelled. In this research, we explored the impact of two BTKi with different selectivity, ibrutinib and zanubrutinib, on haemostasis and thrombosis by differentially modulating the bidirectional signalling of platelet integrin αIIbβ3. We found that both BTKi differentially regulate collagen‐induced GPVI signalling, with ibrutinib more strongly inhibiting the activation of platelets and integrin αIIbβ3 than zanubrutinib. Clot retraction and laser confocal microscopy assays demonstrated that both BTKi can modulate clot retraction and platelet spreading via influence on integrin αIIbβ3 outside‐in signalling, with ibrutinib showing a stronger inhibitory effect. Experiments involving tail bleeding and ferric chloride‐induced thrombosis in rats reflected the differential impact on haemostasis and thrombosis. Notably, the downstream signalling of the integrin αIIbβ3 outside‐in pathway is significantly influenced by ibrutinib, unlike zanubrutinib, through the BTK/PLCγ2/PKCθ pathway. These findings demonstrate that the selectivity of ibrutinib and zanubrutinib leads to different inhibitory effects on platelets and integrin αIIbβ3 activation. Enhanced inhibition of the BTK/PLCγ2/PKCθ signalling pathway by ibrutinib can increase the bleeding risk related to BTKi.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Agammaglobulinaemia Tyrosine KinaseThrombosisPlatelet Membrane GlycoproteinsSignal TransductionPlatelet Glycoprotein GPIIb-IIIa ComplexBlood PlateletsProtein Kinase InhibitorsPyrazolesPyrimidinesHemostasisAnimalsRatsPiperidinesAdeninePhospholipase C gammaHumansMaleTyrosine Kinase Inhibitors

Stichwörter der Autor:innen

BTKi selectivitybidirectional signallingdifferential regulatoryhaemostasis and thrombosisplatelet integrin αIIbβ3

Substanzen

Agammaglobulinaemia Tyrosine KinasePlatelet Membrane Glycoproteinsibrutinibplatelet membrane glycoprotein VIPlatelet Glycoprotein GPIIb-IIIa ComplexProtein Kinase InhibitorsPiperidinesPyrazolesPyrimidinesAdenine

Autor:innen und Institutionen

  • Department of Pharmacy, First Affiliated Hospital of Anhui Medical University, Hefei, China.
  • School of Pharmacy, Anhui Medical University, Hefei, China.
  • Department of Hematology, First Affiliated Hospital of Anhui Medical University, Hefei, China.

ORCID-Profile: Quan Xia

Förderung

  • National Natural Science Foundation of China
  • Traditional Chinese Medicine Inheritance and Innovation Research Project of Anhui Province

Zitieren

APA

Zhang, T., Du, S., Han, G., Shi, H., Cheng, Z., Wang, S., Guan, Y., Long, Z., & Xia, Q. (2025). Differential modulation of Bruton's tyrosine kinase inhibitor selectivity on platelet GPVI and integrin αIIbβ3 bidirectional signalling via BTK / PLCγ2 / PKCθ affects haemostasis and thrombosis. British Journal of Haematology. https://doi.org/10.1111/bjh.70029

Vancouver

Zhang T, Du S, Han G, Shi H, Cheng Z, Wang S, et al. Differential modulation of Bruton's tyrosine kinase inhibitor selectivity on platelet GPVI and integrin αIIbβ3 bidirectional signalling via BTK / PLCγ2 / PKCθ affects haemostasis and thrombosis. British Journal of Haematology. 2025. doi:10.1111/bjh.70029

BibTeX
@article{Zhang2025,
  author = {Zhang, Teng and Du, Shan and Han, Gongwei and Shi, Hanbing and Cheng, Ziwei and Wang, Shuhui and Guan, Yuxuan and Long, Zhangbiao and Xia, Quan},
  title = {Differential modulation of Bruton's tyrosine kinase inhibitor selectivity on platelet GPVI and integrin αIIbβ3 bidirectional signalling via BTK / PLCγ2 / PKCθ affects haemostasis and thrombosis},
  journal = {British Journal of Haematology},
  year = {2025},
  doi = {10.1111/bjh.70029}
}
Infokarte | EUVIMED

Artikeldaten derzeit nicht verfügbar.

Recherche